Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 double-blind randomized study of remimazolam (ONO-2745) in general anesthesia
jRCT2080221932Phase 3
- Sponsor
- Ono Pharmaceutical
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of remimazolam in None, sponsored by Ono Pharmaceutical.
02
Drugs
remimazolam
Beyond the preview
Go deeper on jRCT2080221932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221932.